| Project/Area Number |
23790905
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Respiratory organ internal medicine
|
|---|
| Research Institution | Hamamatsu University School of Medicine |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | 気道炎症 / IL-17C / 気管支喘息 / Toll-like receptor / 粘液過剰産生 / MUC5AC / MUC5B / 気道生体防御 / 気道上皮細胞 / PolyI:C / 上皮産生性サイトカイン / 抗菌ペプチド |
|---|
| Research Abstract |
The present study was conducted to elucidate the mechanisms of mucus overproduction and airway inflammation in exacerbation of asthma.
Co-treatment with NF-kappa B activators and STAT6 activators did not show synergistic mucin genes expression in normal human bronchial epithelial (NHBE) cells. We demonstrated that polyI:C, the ligand to Toll-like receptor 3, induced IL-17C expression via TRIF/NF kappa B pathway in NHBE cells. Both IL-17C and polyI:C increased the expression of antimicrobial peptides and proinflammatory cytokines, such as human beta-defensin (hBD) 2, colony-stimulating factor (CSF) 3, and S100A12 in NHBE cells. Knockdown of IL-17 receptor E, the specific receptor for IL-17C, attenuated polyI:C-induced hBD2, CSF3, and S100A12 expression, without any reduction of polyI:C-induced IL-17C expression, which suggest that IL-17C is an essential epithelial cell-derived cytokine that enhances airway inflammation in a unique autocrine/paracrine manner in the airway epithelium.
|
